纤维素-白蛋白比率与ST段升高的甘西尼分数的相关性心肌梗塞
在PubMed上查看摘要
概括
此摘要是机器生成的。在ST段升高心肌梗塞 (STEMI) 患者中,纤维素与白蛋白比率 (FAR) 与冠状动脉疾病严重程度无关. 这种简单的炎症标记在急性冠状动脉事件中可能具有有限的预后价值.
科学领域
- 心脏病学
- 生物标志物
- 炎症发生
背景情况
- ST段升高心肌梗塞 (STEMI) 是与全身炎症相关的冠状动脉疾病 (CAD) 的严重表现.
- 纤维素与白蛋白的比率 (FAR) 是一种用于预后评估的新型炎症标志物.
- 根西尼评分通过冠状动脉扫描量化CAD的严重程度.
研究的目的
- 在被诊断患有STEMI的患者中,评估纤维素与白蛋白比率 (FAR) 与根西尼分数之间的关联.
主要方法
- 一项涉及70名STEMI患者的横截面观察研究.
- 评估包括临床评估,血液检测 (纤维素,白蛋白),心声学和冠状动脉血管学.
- FAR计算为纤维素/白蛋白;根西尼得分确定了CAD的严重程度. 统计分析包括皮尔森的相关性.
主要成果
- 在FAR和Gensini得分之间没有观察到统计学意义上的相关性 (r=- 0. 002; p=0. 989).
- 根西尼分数与冠状动脉疾病的程度之间存在显著的关联 (p=0.0001).
- FAR与心力衰竭类型没有显著关联.
结论
- 在预测STEMI患者血管学严重性的过程中,纤维素与白蛋白的比率 (FAR) 是有限的.
- 虽然FAR是一种经济的炎症标志物,但其在急性冠状动脉事件中的预后相关性需要进一步调查.
- 需要进行更大的队列研究来验证FAR在STEMI中的临床适用性.
相关概念视频
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

